- Category
- Micro (2021-22)
- Udyam number
- UDYAM-KL-01-0012159

About Hyerose Pharma Private Limited
Data last updated:
Hyerose Pharma Private Limited is a private limited company based in Chengannur, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 July 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U51909KL2018PTC054088. Its GSTIN is 32AAECH6043H1ZV (Kerala).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Deepak Gopinatha Panikker and Gowrinandana Deepak.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2/416 Thiruvanvandoor, Chengannur, Kerala, India – 689109.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.37 Lakh, a growth of 63% compared to the previous year. For the same year it recorded a net profit of ₹20,929 (net margin 0.6%) and EBITDA of ₹1.21 Lakh (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years and 16% over five years.
As per MCA filings, the company has open charges of ₹8.96 Lakh on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Hyerose Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-01-0012159). For more details, the company can be reached via its website hyerosepharma.com.
Company details
Recognitions & Rankings of Hyerose Pharma
Contact details
Hyerose Pharma Private Limited's registered office is in Chengannur, Kerala. Its website is hyerosepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address2/416 Thiruvanvandoor, Chengannur, Kerala, India – 689109
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Hyerose Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hyerose Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Hyerose Pharma Private Limited, buy the company report.
Financials of Hyerose Pharma Private Limited
FY 2025 filings availableHyerose Pharma Private Limited reported revenue of ₹37.37 Lakh (up 63% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 63% growth in the latest year. EBITDA fell 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.21 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹20,929 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hyerose Pharma Private Limited, buy the company report.
Board of directors of Hyerose Pharma Private Limited
Hyerose Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Gopinatha Panikker | Director | 18 Jul 2018 | 8 Years 4 Months | Current |
| Gowrinandana Deepak | Director | 16 Jan 2025 | 1 Years 10 Months | Current |
Auditor
Hyerose Pharma Private Limited is audited by SASI VIJAYAN & RAJAN for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SASI VIJAYAN & RAJAN | FY 2019 | 003629S |
Shareholding
The shareholding of Hyerose Pharma Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Hyerose Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Jun 2020 | 100343144 | Others | ₹1.46 Lakh | Open | |
| 03 Nov 2018 | 100218313 | Others | ₹7.5 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
Hyerose Pharma Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Alappuzha, Kerala | Criminal miscellaneous application | Filed against the company | Pending |
To see the full case history of Hyerose Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hyerose Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hyerose Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAECH6043H1ZV | Kerala | Active | 02 Aug 2018 |
To see the full GST registrations and return filing status of Hyerose Pharma Private Limited, buy the company report.
Recent activity
Hyerose Pharma Private Limited has 5 board changes on record since 2018: 3 appointments and 2 cessations. The latest: Deepak Devinandana ceased to be Director on 16 Jan 2025.
Frequently asked questions
Hyerose Pharma is an active private limited company based in Chengannur, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 July 2018 (8+ years old) and is registered under CIN U51909KL2018PTC054088.
Hyerose Pharma has 2 current directors:
- Deepak Gopinatha Panikker - Director
- Gowrinandana Deepak - Director
The latest financial statements of Hyerose Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Hyerose Pharma is 32AAECH6043H1ZV, registered in Kerala.
The CIN (Corporate Identification Number) of Hyerose Pharma is U51909KL2018PTC054088. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hyerose Pharma has 1 court case on record: 1 filed against it. 1 is pending.
Hyerose Pharma was incorporated on 18 July 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ernakulam.
Deepak Devinandana ceased to be Director on 16 Jan 2025. Gowrinandana Deepak was appointed as Director on 16 Jan 2025. Deepak Devinandana was appointed as Director on 05 Dec 2022. Hyerose Pharma has 5 board changes on record in total.
Yes, Hyerose Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-01-0012159).
Hyerose Pharma can be reached through the website hyerosepharma.com. Its registered office is in Chengannur, Kerala, India.

